Treatment-related mortality in children with acute lymphoblastic leukemia in Central America

Cancer

Volumn 117, Issue 20, 2011, Pages 4788-4795

  Gupta, Sumit ^a   Antillon, Federico A ^b   Bonilla, Miguel ^c   Fu, Ligia ^d   Howard, Scott C ^e   Ribeiro, Raul C ^e   Sung, Lillian ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b National Pediatric Oncology Unit   (Guatemala)

^c Benjamin Bloom National Children's Hospital   (El Salvador)

^d Hospital Escuela   (Honduras)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

acute lymphoblastic leukemia; Central America; child; developing countries; treatment related death

Indexed keywords

ANTINEOPLASTIC AGENT; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RISK; CENTRAL AMERICA; CHILD; CHILD DEATH; COHORT ANALYSIS; DRUG FATALITY; DRUG MEGADOSE; FEMALE; HUMAN; INFANT; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT TRANSPORT; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; THROMBOCYTE COUNT; TREATMENT RELATED MORTALITY;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; EL SALVADOR; FEMALE; GUATEMALA; HEALTH SERVICES ACCESSIBILITY; HEMORRHAGE; HONDURAS; HUMANS; INFECTION; MALE; ODDS RATIO; PLATELET COUNT; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REMISSION INDUCTION; RESEARCH DESIGN; RISK FACTORS; YOUNG ADULT;

EID: 80053917202     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26107     Document Type: Article

References (29)

1. Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009; 360: 2730-2741.
2. Moghrabi A, Levy DE, Asselin B, et al. Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood. 2007; 109: 896-904. (Pubitemid 46220632)
3. Mostert S, Sitaresmi MN, Gundy CM, Sutaryo, Veerman AJ,. Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia. Pediatrics. 2006; 118: e1600-1606. (Pubitemid 46397531)
4. Metzger ML, Howard SC, Fu LC, et al. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries. Lancet. 2003; 362: 706.
5. Howard SC, Wilimas JA,. Delays in diagnosis and treatment of childhood cancer: where in the world are they important? Pediatr Blood Cancer. 2005; 44: 303-304. (Pubitemid 40316022)
6. Li CK, Chik KW, Chan GC, et al. Treatment of acute lymphoblastic leukemia in Hong Kong children: HKALL 93 Study. Hematol Oncol. 2003; 21: 1-9. (Pubitemid 36356239)
7. Rubnitz JE, Lensing S, Zhou Y, et al. Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience. Cancer. 2004; 101: 1677-1684. (Pubitemid 39318917)
8. Slats AM, Egeler RM, van der Does-van den Berg A, et al. Causes of death-other than progressive leukemia-in childhood acute lymphoblastic leukemia (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience. Leukemia. 2005; 19: 537-544. (Pubitemid 40521157)
9. Christensen MS, Heyman M, Mottonen M, et al. Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992-2001. Br J Haematol. 2005; 131: 50-58. (Pubitemid 43899707)
10. Hargrave DR, Hann IM, Richards SM, et al. Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI). Br J Haematol. 2001; 112: 293-299. (Pubitemid 32183469)
11. Prucker C, Attarbaschi A, Peters C, et al. Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Munster Study Group. Leukemia. 2009; 23: 1264-1269.
12. Aziz Z, Zahid M, Mahmood R, Maqbool S,. Modified BFM protocol for childhood acute lymphoblastic leukemia: a retrospective analysis. Med Pediatr Oncol. 1997; 28: 48-53. (Pubitemid 27023776)
13. Advani S, Pai S, Adde M, et al. Acute lymphoblastic leukemia in India: an analysis of prognostic factors using a single treatment regimen. Ann Oncol. 1999; 10: 167-176. (Pubitemid 29113176)
14. Laosombat V, Wongchanchailert M, Sattayasevana B, Wiriyasateinkul A, Watana-Arepornchai S,. The treatment of children with acute lymphoblastic leukemia in Thailand. Med Pediatr Oncol. 2002; 38: 266-268. (Pubitemid 34258420)
15. Howard SC, Pedrosa M, Lins M, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA. 2004; 291: 2471-2475. (Pubitemid 38669191)
16. Gupta S, Bonilla M, Fuentes SL, et al. Incidence and predictors of treatment-related mortality in paediatric acute leukaemia in El Salvador. Br J Cancer. 2009; 100: 1026-1031.
17. Pui CH, Sandlund JT, Pei D, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood. 2004; 104: 2690-2696. (Pubitemid 39434949)
18. Arora RS, Eden T, Pizer B,. The problem of treatment abandonment in children from developing countries with cancer. Pediatr Blood Cancer. 2007; 49: 941-946. (Pubitemid 350022449)
19. Bonilla M, Rossell N, Salaverria C, et al. Prevalence and predictors of abandonment of therapy among children with cancer in El Salvador. Int J Cancer. 2009; 125: 2144-2146.
20. Ayoub L, Fu L, Pena A, et al. Implementation of a data management program in a pediatric cancer unit in a low income country. Pediatr Blood Cancer. 2007; 49: 23-27. (Pubitemid 46847064)
21. The World Bank. World Development Indicators. Accessed November 24, 2009.
22. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002; 109: 45-60. (Pubitemid 34049426)
23. Sala A, Rossi E, Antillon F,. Nutritional status at diagnosis in children and adolescents with cancer in the AHOPCA (Asociacion de Hemato-Oncologia Pedatrica de Centro America) countries. Preliminary results from Guatemala. Pediatr Blood Cancer. 2008; 50 (2 suppl): 499-501.
24. Frisancho AR,. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr. 1981; 34: 2540-2545. (Pubitemid 12176089)
25. Lange BJ, Smith FO, Feusner J, et al. Outcomes in CCG-2961, a Children's Oncology Group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Blood. 2008; 111: 1044-1053. (Pubitemid 351213382)
26. Gibson BES, Wheatley K, Hann IM, et al. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia. 2005; 19: 2130-2138. (Pubitemid 41741605)
27. Tang Y, Xu X, Song H, Yang S, Shi S, Wei J,. Long-term outcome of childhood acute lymphoblastic leukemia treated in China. Pediatr Blood Cancer. 2008; 51: 380-386.
28. Viana MB, Fernandes RA, de Oliveira BM, Murao M, de Andrade Paes C, Duarte AA,. Nutritional and socio-economic status in the prognosis of childhood acute lymphoblastic leukemia. Haematologica. 2001; 86: 113-120. (Pubitemid 32216082)
29. Bonilla M, Gupta S, Vasquez R, et al. Predictors of outcome and methodological issues in children with acute lymphoblastic leukemia in El Salvador. Eur J Cancer. 2010; 46: 3280-3286.